Enhanced Tim3 Activity Improves Survival After Influenza Infection1,2,3
Influenza is a major cause of morbidity and mortality in the United States. Studies have shown that excessive T cell activity can mediate pneumonitis in the setting of influenza infection, and data from the 2009 H1N1 pandemic indicate that critical illness and respiratory failure following infection...
Gespeichert in:
Veröffentlicht in: | The Journal of immunology (1950) 2012-08, Vol.189 (6), p.2879-2889 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Influenza is a major cause of morbidity and mortality in the United States. Studies have shown that excessive T cell activity can mediate pneumonitis in the setting of influenza infection, and data from the 2009 H1N1 pandemic indicate that critical illness and respiratory failure following infection was associated with greater infiltration of the lungs with CD8
+
T cells. T cell immunoglobulin and mucin domain 3 (Tim3) is a negative regulator of Th1/Tc1-type immune responses. Activation of Tim3 on effector T cells has been shown to down-regulate proliferation, cell-mediated cytotoxicity, and IFNγ production as well as induce apoptosis. Here, we demonstrate that deletion of the terminal cytoplasmic domain of the
Tim3
gene potentiates its ability to down-regulate Tc1 inflammation and that this enhanced Tim3 activity is associated with decreased phosphorylation of the TCR-CD3ζ chain. We then show that mice with this
Tim3
mutation infected with influenza are protected from morbidity and mortality without impairment in viral clearance or functional heterotypic immunity. This protection is associated with decreased CD8
+
T cell proliferation and decreased production of inflammatory cytokines, including IFNγ. Furthermore, the Tim3 mutation was protective against mortality in a CD8
+
T cell-specific model of pneumonitis. These data suggest that Tim3 could be targeted to prevent immunopathology during influenza infection and demonstrate a potentially novel signaling mechanism utilized by Tim3 to down-regulate the Tc1 response. |
---|---|
ISSN: | 0022-1767 1550-6606 |
DOI: | 10.4049/jimmunol.1102483 |